Podcasts about Kidney cancer

Food manufacturers cave to RFK Jr. agenda to eliminate artificial dyes; Diet, exercise ameliorate tinnitus symptoms in overweight seniors; Long work hours may foster deleterious brain changes; Blood in urine—why is it such a big deal? Suggestions for a dog with panic attacks ahead of weather fronts; Diets high in fruits and vegetables counter disordered sleep.

Recorded live in Chicago, your hosts explore the latest in kidney cancer, discussing new five-year follow-up data from KEYNOTE-564, the long-term results of CheckMate 214, insights from the ongoing PDIGREE trial, and much more.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, Ipsen, J&J, Merck, Pfizer, Eisai and AbbVie.

The Sounds of Nouns & Ozempic Linked to Kidney CancerSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this panel discussion, UROONCO RCC associate editor Dr. Teele Kuusk talks to EAU RCC guidelines panel members Prof. Axel Bex and Assoc. Prof. Saeed Dabestani on the 2025 updates in the EAU Guidelines for renal cell carcinoma (RCC). Their conversation includes the impact of KEYNOTE-564 on adjuvant therapy, recommendations for stereotactic body radiotherapy (SBRT), surgical approaches, systemic therapies for papillary RCC, and new trial data. They also share insights into ongoing research on liquid biomarkers and perioperative treatment strategies. 

At the 2025 American Urological Association (AUA2025) Meeting in Las Vegas, UROONCO RCC associate editor Dr. Riccardo Bertolo (IT) spoke with Prof. Riccardo Autorino (US) about multi-port and single-port surgery options for kidney cancer. Prof. Autorino shares expert insights on the key features of both surgical platforms, discussing their advantages and disadvantages, as well as considerations for selecting the most suitable patients for each approach.For more updates on kidney cancer, please visit our educational platform UROONCO RCC.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

More great highlights from the latest edition of European Urology! Here on the European Urology Podcast we bring you selected highlights from the journal each month with some great guests. As ever we highlight two key papers (details below) from this month's journal, including interviews with key authors. With co-Hosts Professor Declan Murphy (Melbourne, Australia), and Dr Nikita Bhatt (Newcastle, UK). We also catch up with one of our recent Award Winners, Dr Laura Elst (Leuven, BEL), who who won the Best Translational Paper Award 2024. Even better on our YouTube channelPodcast Priority Papers1 . Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study.Featured author - Dr Stephen Freedland (Cedars-Sinai Medical Center, USA)2. Abdominal Noncontrast Computed Tomography Scanning to Screen for Kidney Cancer and Other Abdominal Pathology Within Community-based Computed Tomography Screening for Lung Cancer: Results of the Yorkshire Kidney Screening Trial. https://www.europeanurology.com/article/S0302-2838(24)02567-3/fulltextFeatured author - Prof Grant Stewart (Cambridge)Best Translational Paper Award 2024 - Dr Laura Elst (Leuven, BEL); Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.  Full index to European Urology May 2025 

While rubbing her 3 year old daughter Chelsea's belly, Alison Hicks felt a lump which was shortly diagnosed as a Stage 4 Wilms Tumor. Chelsea fought this Pediatric  Kidney Cancer for nearly 2 years before passing away after a treatment protocol which was very difficult from the beginning to its end. As a result of Chelsea's battle and passing, Alison started the Chelsea Hicks Foundation which focuses on keeping a smile on Pediatric Cancer patients as they go through their impatient hospital treatments. 

Jeff Kallis survived renal cell carcinoma, a form of kidney cancer.  When he experienced pain in his lower flank and saw blood in his urine, he sought medical attention.  A CT urogram revealed a stone in his left kidney and a mass in his right kidney.  A biopsy confirmed he had clear cell renal cell carcinoma.  Jeff underwent a radical nephrectomy on his right kidney.  The operation was painful, but a success.  Through exercise and a healthy diet, Jeff tells the @CancerInterviews podcast he feels better than he did before his diagnosis.

Hereditary Kidney Cancer Syndromes CME Available: https://auau.auanet.org/node/41772 ACKNOWLEDGEMENTS: Support provided by an independent educational grant from:  Merck & Co., Inc.  LEARNING OBJECTIVES: At the conclusion of this activity, participants should be able to: 1. Select patients who should undergo genetic testing to identify hereditary kidney cancer syndromes based on appropriate criteria, including family history and clinical presentation. 2. Implement strategies to address ethical concerns related to genetic testing, such as patient consent, confidentiality, and the potential impact on family members. 3. Discuss VHL syndrome, including its genetic basis, inheritance pattern, and associated tumors. 4. Properly diagnose and manage VHL syndrome in clinical practice based on knowledge of novel therapeutic strategies. 5. Utilize a multidisciplinary approach consisting of urologists, oncologists, geneticists and nephrologists when managing hereditary kidney cancer syndromes.

Kidney cancer is one of the deadliest cancers, and a therapeutic vaccine shows promising results, offering new hope for those suffering with the disease. Dr. David Braun, a medical oncologist and researcher at Yale Cancer Center is here – he was the principal investigator on the kidney cancer vaccine study that published in the medical journal, Nature. Image Credit: Getty Images

Watch the show on YouTube: https://www.youtube.com/@DrTazMD/podcastsIn this episode, Cameron Mathison sits down with Dr. Taz to share his incredible and inspiring health journey. From his early challenges with a degenerative bone disease to a shocking kidney cancer diagnosis, Cameron's story underscores the importance of being an advocate for one's own health. He reveals how, for years, he was misled by traditional doctors who simply prescribed medications that only made things worse, until he found a path to healing through functional medicine. Cameron discusses his approach to integrating science and spirit, the pivotal role of a functional health coach in his recovery, and his newfound passion for helping others through his venture, Health360. Join us for a compelling story of resilience, the power of functional medicine, and the importance of holistic health practices.Note: This conversation was filmed before Cameron and his family lost their house in the LA fires. Healing is a constant journey and we are sending Cameron and his family lots of love. About Cameron MathisonEmmy nominated actor and Emmy winning TV host Cameron Mathison made his long-awaited return to daytime on ABC's General Hospital, after a decade as fan favorite Ryan Lavery on ABC's All My Children.  He was also the co-host of Hallmark Channel's “Home and Family” alongside Debbie Matenopoulos for three seasons. Mathison is also the creator of allhealth360, a health and wellness destination dedicated to a healthier lifestyle inside and out. He previously served as feature correspondent for “Good Morning America,” “Entertainment Tonight” and “Extra,” and co-hosted the “35th Annual Daytime Emmy Awards.” He recently signed a multi-picture deal with Great American Media and is a host for a new GSN show that is set to premiere in 2024.Thank you to our sponsorTimeline: timeline.com/DRTAZ01:54 A Personal Story from Dr. Taz03:15 Advocating for Men's Health05:50 Cameron's Early Life Health Struggles14:51 Discovering Kidney Cancer17:05 The Healing Journey Begins20:19 The Role of Functional Health Coaching27:57 Cameron's Gut Health Protocol35:42 Cameron's Personal Experience with Healing His Gut43:17 Meditation and Mental Well-being56:10 Encouragement for Men's HealthStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Cameron Matthison:https://www.instagram.com/cameronmathison/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+

In this episode, UROONCO kidney cancer chief editor Dr. Carmen Mir talks to Assoc. Prof. Tian Zhang from UT Southwestern Medical Center (USA). Assoc. Prof. Zhang shares an overview on the trial results of metastatic kidney cancer (mRCC) that were discussed at ASCO GU25. These trials include CheckMate-9ER, COSMIC-313, KEYMAKER-U03, LITESPARK-011. Assoc. Prof. Zhang gives her expert opinion on how these trials could impact clinical practice on first-line kidney cancer treatment. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Episode 19 is the final part of a mini-series from the 2025 ASCO Genitourinary Cancers Symposium in San Francisco! After diving into prostate and bladder cancers in the first two episodes, Dr. Aly-Khan Lalani and Dr. Christopher Wallis are wrapping with an in-depth look at kidney cancer, diving into research, studies and developments shared at the symposium. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take-home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Bayer, Astellas, J&J, Tolmar, Merck, and Pfizer.

Host Annamaria Scaccia takes a deep dive into the connection between plastic pollution and kidney cancer with Dr. Laura Bukavina and Dr. Christopher Weight from the Cleveland Clinic. Bukavina and Weight explore how environmental exposures impact our health - and why we need to rethink our plastic consumption for the sake of our future and our health. Visit kidneycancer.org for more support and resources. Hosted on Acast. See acast.com/privacy for more information.

T. Colin Campbell explains the scientific reasons behind plant-based nutrition. Discover how fundamental science supports the benefits of consuming plants for optimal health and disease prevention. #PlantBased #NutritionalScience #HealthBenefits

Heard the shocking vaccine claims by RFK Jr. that have medical professionals concerned? In this eye-opening replay of Medical Mondays, I'm breaking down the dangerous misconceptions about race-based vaccine scheduling. As a board-certified physician I'll separate fact from fiction and explain why these claims put communities at risk.We're also discussing NBA star Dwyane Wade's recent kidney cancer diagnosis - a powerful reminder that knowing your body's signals can save your life. I'll share the critical symptoms you shouldn't ignore and explain when it's time to see your doctor.Plus, get the latest updates on the Kansas TB outbreak and California's bird flu situation. And let's talk about Hollywood's weight struggles - from Luther Vandross's powerful comeback to fat-shaming, to Lizzo's body positivity message, and the important conversation about Tracey Gold's battle with anorexia. Join me for this crucial discussion where we tackle these pressing health issues with medical accuracy and compassion.This podcast is intended to be informational only.  It is not a medical consultation, nor is it personalized medical advice.  For medical advice, please consult your physician.Here are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a video.

The UROONCO RCC editorial board chief editor Dr. Carmen Mir, and associate editors Dr. Teele Kuusk and Dr. Riccardo Bertolo share highlights of the important kidney cancer developments for 2024. They summarise the results on several important trials such as FASTRACK, ZIRCON, KEYNOTE-564 and IMmotion010. They also discuss the developments on surgical aspects too.To learn more on the highlights discussed in this podcast, you can read the below Articles of the Month, listen to the podcasts or watch the videos.Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptideASCO2024 special: Circulating kidney injury molecule-1 biomarker analysis in IMmotion010Present and future of robotic surgery for RCCThe treatment of locally advanced and metastatic renal cancerFor more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, Google Podcasts.

For patients with early-stage cancer, minimally invasive image-guided therapies like cryoablation can be both life-altering and life-saving. Patient Clinton Lanier, a kidney cancer survivor who underwent multiple cryoablations, sits down with host Dr. Eric Keller to share his story and raise patient-provider awareness of the positive impacts IR brings. --- This podcast was developed in collaboration with: Interventional Initiative https://theii.org/ --- SYNPOSIS Clinton shares his personal story of being diagnosed with a kidney tumor during a sailing trip and discovering cryoablation as a treatment option through his own research and advocacy. He discusses the effectiveness and ease of the procedure, the positive impact it has had on his quality of life, and the importance of raising awareness about cryoablation among patients and healthcare providers. --- TIMESTAMPS 00:00 - Introduction 03:56 - First Cryoablation Experience 05:20 - Patient Experience 09:12 - Cryoablation Awareness 14:44 - Conclusion --- RESOURCES The Interventional Initiative: https://theii.org

Prof. Jens Bedke (DE) talks about two key topics from this year's EMUC24 kidney cancer sessions: the role of cytoreductive nephrectomy, and the SUNNIFORECAST trial (prospective randomised phase 2 trial of ipilimumab + nivolumab versus standaard of care in non-clear cell RCC.)This informative episode was recorded at the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) in Lisbon, Portugal.  For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Heather Williams faced the unimaginable, receiving a rare kidney cancer diagnosis and finding out she was pregnant in the span on 13 days. Heather was just over a year into marriage to the love of her life and they hoped to start a family. With host Annamaria Scaccia, Heather shared the challenges of undergoing treatment for the rare type of kidney cancer called renal medullary carcinoma (RMC) while pregnant and the unwavering support from her medical team. Visit kidneycancer.org for more support and resources. Hosted on Acast. See acast.com/privacy for more information.

Hereditary Kidney Cancer Syndromes CME Available: https://auau.auanet.org/node/41772 ACKNOWLEDGEMENTS: Support provided by an independent educational grant from:  Merck & Co., Inc.  LEARNING OBJECTIVES: At the conclusion of this activity, participants should be able to: 1. Select patients who should undergo genetic testing to identify hereditary kidney cancer syndromes based on appropriate criteria, including family history and clinical presentation. 2. Implement strategies to address ethical concerns related to genetic testing, such as patient consent, confidentiality, and the potential impact on family members. 3. Discuss VHL syndrome, including its genetic basis, inheritance pattern, and associated tumors. 4. Properly diagnose and manage VHL syndrome in clinical practice based on knowledge of novel therapeutic strategies. 5. Utilize a multidisciplinary approach consisting of urologists, oncologists, geneticists and nephrologists when managing hereditary kidney cancer syndromes.

Mallory Foxx is a kidney cancer survivor and the 2023 Mrs. Black International Ambassador, a title she won while preparing for surgery. In conversation with host Annamaria Scaccia, Mallory's story is a reminder of the importance of advocating for yourself, building a strong support network, and finding multiple communities. Visit kidneycancer.org for more support and resources. Hosted on Acast. See acast.com/privacy for more information.

Workup and management of Kidney Cancer in Radiation Oncology featuring guest Dr Riche Mohan

Megan Nelson's mom felt an odd lump as she was hugging her 2 year old granddaughter Ella before returning home after Megan had given birth to her son Francis in 2020. Upon hearing this, Megan took Ella to her pediatrician and shortly thereafter she was diagnosed with the Kidney Cancer Wilms Tumor before this diagnosis was changed 3 days later to Stage 4 High Risk Neuroblastoma. Megan and her family were living in Virginia at the time but moved to Los Angeles so Ella could get her treatment at the Children's Hospital of Los Angeles. Now 4 years later, Ella is doing well and is living her best life possible. 

Wrapping up their ESMO Congress 2024 coverage with a discussion of renal cancer, our hosts talk about what strategies work (or don't) after frontline therapy for mRCC, implications on adjuvant therapy, as well as major efforts for non-clear cell histologies like the SUNNIFORECAST trial. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.ca This podcast has been made possible through unrestricted financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, J&J Innovative Medicine, Merck, Novartis, Pfizer, TerSera.

Join host Annamaria Scaccia as we kick off season 2 of Kidney Cancer Unfiltered with a deeply moving episode featuring the Sanders family. Hear from Alexandra Sanders, mother to Andre "Dre" Sanders, who has a kidney cancer diagnosis, about pediatric kidney cancer, the unique challenges of his treatment, and the life-altering effects on his entire family. Visit kidneycancer.org for more support and resources. Hosted on Acast. See acast.com/privacy for more information.

Welcome back for season 2 of Kidney Cancer Unfiltered, a podcast by the Kidney Cancer Association. Host and kidney cancer survivor Annamaria Scaccia leads candid conversations with people impacted by kidney cancer to dive deep into the raw, unfiltered stories that often go untold. In each episode, we explore the emotional rollercoaster of kidney cancer and how to come out resilient. Because when it comes to kidney cancer, every story deserves to be heard, unfiltered. Subscribe and join us every week for conversations that matter.For more information about kidney cancer, visit the Kidney Cancer Association at www.kidneycancer.org. Hosted on Acast. See acast.com/privacy for more information.

Kidney Cancer & SBRT in the Management of RCC AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS, FRCS(Glasg) Guest: Daniel Shapiro, MD Outline: Segment 1: History of radiation therapy in renal cell carcinoma Segment 2: Radiation use in the setting of primary kidney tumors Segment 3: Radiation use for locally advanced tumors including tumor thrombi Segment 4: Radiation therapy for metastatic disease Segment 5: Limitations of radiation therapy and selecting patients for radiation therapy

New treatments and managing side effects are key challenges in kidney cancer care. In our latest episode of The PQI Podcast, we team up with the Kidney Cancer Association, Emily Wang, PharmD, BCOP, from MD Anderson, and Julia Stevens, PharmD, BCOP, from Beth Israel Deaconess, to share valuable insights into the newest advancements in kidney cancer therapies and practical strategies for managing side effects from TKI and IO treatments. Listen now to gain valuable knowledge that can transform your patient care approach.Learn more about the Kidney Cancer Association here. 

Harnessing the Immune System to Treat Kidney Cancer with guest David Braun MD, PhD, August 11, 2024

We were very happy to have world-famous kidney cancer guru Dr Rana McKay in Australia this week to do some educational events and to visit us at Peter Mac. So of course we also invited her to the GU Cast studio to pick her brains on all things kidney cancer, along with Dr Lewis Au, GU Medical Oncologist at Peter Mac. We asked them to cover three hot topics: 1. Adjuvant immunotherapy following surgery for kidney cancer2. First line management of metastatic kidney cancer - how do we choose best options for individual patients?  3. Future-gazing in renal cancer, including a focus on belzutifan.Even better on our YouTube channel Rana's visit to Australia was supported by our friends at MSD, Silver Partners of GU Cast. Links: Previous GU Cast on Keynote-564Renu's new paper in Nature Reviews Urology! (mentioned in the intro) 

At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with various experts in the kidney cancer field about potential advancements in disease detection and updated efficacy data on immunotherapy and other treatment strategies in patients with renal cell carcinoma (RCC). Karl Semaan, MD, MSc, a postdoctoral oncology research fellow at Dana-Farber Cancer Institute, discussed the implications of findings related to the use of an investigational tissue-informed liquid biopsy epigenomic profiling tool for detecting sarcomatoid differentiation in RCC.1 According to Semaan, this method may avoid the sampling errors and spatial heterogeneity challenges associated with traditional biopsy strategies. Additionally, Neil J. Shah, MBBS, an assistant attending physician from Memorial Sloan Kettering Cancer Center, spoke about data from a real-world study evaluating treatment patterns and outcomes in those with metastatic RCC following prior receipt of immunotherapy and tyrosine kinase inhibitors (TKIs).2 Data showed no differences in overall survival (OS) outcomes across different immunotherapy- and TKI-containing regimens. Based on these findings, Shah emphasized a need for additional novel therapeutic approaches to help improve outcomes in later-line settings of treatment. Bradley A. McGregor, MD, director of Clinical Research for the Lank Center of Genitourinary Oncology and medical oncologist specializing in genitourinary malignancies at Dana-Farber Cancer Institute, highlighted findings from his presentation on a phase 1b study (NCT04627064) evaluating treatment with abemaciclib (Verzenio) in a pretreated metastatic clear cell RCC population.3 Among 11 patients who received abemaciclib, 1 had stable disease, 8 had progressive disease, and 2 were not evaluable for response. Additionally, the median progression-free survival (PFS) and overall survival (OS), respectively, was 1.8 months (95% CI, 1.5-1.9) and 9.1 months (95% CI, 2.1-15.3). Although abemaciclib monotherapy yielded no responses in the study, McGregor highlighted the potential clinical utility of administering the agent in combination with other therapies. Findings from his presentation suggested that CDK4/6 inhibitors may demonstrate a synergistic effect when combined with HIF-2α inhibitors, which is a potential strategy that investigators are evaluating with belzutifan (Welireg) and palbociclib (Ibrance) combination therapy as part of the phase 1/2 LITESPARK-024 trial (NCT05468697). References 1.        Semaan K, Zarif TE, Eid M, et al. Liquid biopsy epigenomic profiling for the detection of sarcomatoid renal cell carcinoma. Presented at the 2024 Kidney Cancer Research Summit; July 11-12, 2023; Boston, MA. Abstract 44. 2.        Shah N, Sura S, Shinde R, et al. Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and Vascular Endothelial Growth Factor (VEGF) receptor targeted therapies. Presented at the 2024 Kidney Cancer Research Summit; July 11-12, 2023; Boston, MA. Abstract 36. 3.        McGregor BA, Xie W, Xu W, et al. Phase IB trial of abemaciclib in advanced renal cell carcinoma. Presented at: 2024 Kidney Cancer Research Summit; July 11-12, 2024. Boston, MA.

Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here. (https://www.researchtopractice.com/PostASCO2024/RCC)

In this podcast, UROONCO RCC chief editor Dr. Maria Carmen Mir (ES) talks to Prof. Laurence Albiges (FR) on the abstract she recently presented at ASCO2024 - “Circulating kidney injury molecule-1 (KIM-1) biomarker analysis in IMmotion010: A randomised phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection”.  Prof. Albiges details the two parts of the circulating biomarker analysis scheme, part one - biomarker identification/screening; and part two - assessing the association of circulating kidney injury molecule-1 with disease free survival outcomes.   The study results are discussed in detail and Prof. Albiges talks about what research is needed in the future to confirm the utility of circulating serum kidney injury molecule-1 in adjuvant RCC as a non-invasive biomarker. 

The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.

Toni Choueiri and Brian describe similarities and differences in the biomarker findings of these two trials. Debate about the value and future of this approach breaks out.

Dr. David Braun discusses the exciting advancements in cancer vaccines and immunotherapy. He explains how the immune system can be harnessed to target and eliminate cancer cells, particularly in kidney cancer. He also discusses the potential for preventive vaccines and the future of curative treatments for cancer. This episode offers a fascinating glimpse into the cutting-edge research and possibilities in cancer immunotherapy.

Today's episode we will cover 2024 updates for metastatic renal cell carcinoma. We will discuss risk categories, treatment options, and variant histologies. We are so excited to have Dr. Tom Powles and Dr. Brian Rini from the urologic oncology podcast Uromigos sharing their expertise on today's episode as well!

Today's episode we will cover 2024 updates for localized renal cell carcinoma (RCC). We will discuss risk factors, the presentation, staging, and treatment options. We are so excited to have Dr. Tom Powles and Dr. Brian Rini from the urologic oncology podcast Uromigos sharing their expertise on today's episode as well!

In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant therapy, considerations for genetic testing, and the importance of clinical trial participation for bringing these new advances to the forefront of care.

In this interview for Kidney Cancer Awareness Month, Hiam Abdel-Salam, MS, CGC, speaks with Donika Saporito, MS, a Certified Genetic Counselor in the Genitourinary Center at MD Anderson Cancer Center, who provides an overview of genetic testing for hereditary kidney cancer syndromes and how she personally counsels the patients she sees.

In this episode of Navigating Cancer TOGETHER, join Micheal and Tatiana Parker, a dynamic duo who share their inspiring journey as kidney cancer survivors/thrivers and small minority business owners. From Micheal's unexpected diagnosis to launching their apparel brand, Watch4TheHook, and their insightful podcast, the Parkers provide valuable insights on overcoming challenges, leaving a legacy, and the importance of listening to your body. Tune in for a candid discussion filled with wisdom, resilience, and a reminder that it's okay to not be okay. Join us as we navigate cancer and entrepreneurship together, finding strength in vulnerability and determination in the face of adversity.✨Highlights from the show:[00:05:23] A health scare and revelation.[00:09:56] Handling unexpected medical news.[00:12:18] Challenges of caregiving.[00:17:07] A challenging recovery journey.[00:19:32] Overcoming health challenges for entrepreneurship.[00:25:30] Listening to your body.[00:30:49] Leaving a legacy.

When Vara James was 9 years old in 2016 she was diagnosed with the Kidney Cancer Wilms Tumor. Now 17 years old, Vara has been cancer free since February of 2018 and has many options to look at as she is able to live as normal of a life as possible. Vara and her mother Emily Gordon will talk about these past 8 years which include helping to start the Rock Cancer program along with Neuro Oncologist Dr. Carl Koschmann,  which gives Pediatric Cancer patients the opportunity to gain confidence and a sense of accomplishment by learning to Rock Climb. 

The AUA Expert Exchange Podcast: Discussions in Managing GU Cancer: Adjuvant Therapies for High-Risk Non-Metastatic Kidney Cancer CME Available: https://auau.auanet.org/node/39542 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Identify the rationale behind using adjuvant therapies in high-risk non-metastatic kidney cancer and the goals of adjuvant treatment. 2. Describe the adjuvant therapies that have been investigated to date for high-risk non-metastatic kidney cancer, including targeted therapies, immunotherapies, and combination approaches. 3. Discuss the challenges and limitations associated with adjuvant therapy trials in high-risk non-metastatic kidney cancer, such as patient selection, trial design, and long-term follow-up. ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC  Lantheus Medical Imaging Merck & Co., Inc.

A heartfelt thank you goes out to each of you, our cherished listeners, for joining us today as we unfold the tapestry of Mitchell's battle with kidney cancer. The rollercoaster of emotions and the triumphant news of his complete recovery post-surgery are at the heart of our latest episode. While surrounded by the love of family, and the humorous innocence of his son Zeke, Mitchell's journey is a testament to resilience, with his early discharge from the hospital being just one of the many milestones we celebrate.Venture with us through the charming antics of young Zeke, whose endearing confusion over his dad's surgery and sweet strategies to visit grandma lightened our spirits. As we navigate the post-surgery days, Mitchell's admirable determination shines through, with his swift return to barn activities and woodcutting serving as a beacon of normalcy. Amidst these personal tales, we share in the joy of a family wedding set against the picturesque backdrop of Hocking Hills – a moment of love and commitment that enriches our narrative.In the face of life's unpredictable storms, we delve into the power of faith and the comfort it brings. Our conversation takes a turn towards the spiritual as we open up about our own cancer encounters and the solace found in prayer. The community's prayers played a crucial role when a pre-surgery COVID scare threatened to upend our plans, yet faith prevailed, leading to a miraculous negative test and an affirmation of the profound impact of collective belief. As the year draws to a close, we leave you with thoughts on the strength found in our weaknesses and the uplifting embrace of God's grace, sharing our hopes for the holiday season and the anticipation of our next heart-to-heart on actual faith.Support the showSupport our ministryCheck us out at purefaithliving.comContact us at purefaithliving.com/contactFollow us on twitter @purefaithlivingFollow us on Facebook at Pure Faith Podcast

Back by popular demand! I was so thrilled to get to sit down and chat to one of my first ever guests on Navigating New York, Maurice Barron. Maurice spoke to me in February 2021 after what had been an extremely challenging year for he  and his wife Kandice as their baby girl, Ava, was diagnosed with a rare form of Kidney Cancer with an extremely low survival rate. In our 1st episode, Maurice shared some of the darkest and most challenging moments they experienced during Ava's treatment. Maurice also spoke about how First Lady Jill Biden's book helped him find moments of joy as often as he could. During this time, Maurice sent a letter to the President of the United States about the journey Ava was on, and how inspiring the Biden family had been for them during their darkest moments. What transpired from that letter is a story of hope and belief. I am so thrilled to report that Ava is healthy, happy and changing the world one day at a time! I hope you enjoy this inspiring conversation. This Episode is kindly sponsored by Thérapie Clinic Europe's no.1 Med Spa and an Irish family business that have just moved to NYC and will be expanding with more locations in 2024.  With over 70 clinics in Europe  and currently a gorgeous home here in Manahattan on 19th street – the guys at Thérapie have kindly offered a complimentary underarm treatment to all of our listeners. Just mention the podcast when you get in touch. Thanks for listening!

Imagine you've got your keys in hand, ready to unlock the car to grab the podcast iPad, and you suddenly realize it's not even your vehicle. Laugh with us at this little mix-up and more, as we kick off another episode of Pure Faith Podcast, where we juggle between the hilarious and deeply serious. This time, we're unscripted and unfiltered, with Mitchell sharing an update on his kidney cancer journey, its unexpected link to his military service, and the potential upheavals of his future deployments and retirement plans.Ever wonder why life goes sideways for the good folks around us? It's one of those puzzling questions we're wrestling with, as we reflect on Mitchell's cancer battle and the overwhelming support from our listeners. We're even contemplating a shift in the podcast narrative to focus more on cancer-related topics. We also give you a sneak peek into our upcoming year-in-review episode while we navigate the logistics of recording during Mitchell's recovery phase from surgery.Thinking about the Bible and how to interpret it? Join us as we cast our lens on Matthew 5:19's 'least commandment' and understand how it ties back to Jesus' statement about fulfilling the law and the concept of heaven on earth. We explore how this idea relates to Jesus's critique of Pharisees' interpretation of the law. Remember, even when we stumble and misstep, our faith in Jesus is our key to the kingdom of heaven. So, buckle up and let's set off on this enlightening journey together.Support the showSupport our ministryCheck us out at purefaithliving.comContact us at purefaithliving.com/contactFollow us on twitter @purefaithlivingFollow us on Facebook at Pure Faith Podcast

Ever been on a family trip that turned into a comedy of errors? That's exactly what happened to Mitchell during his recent trip to Greenville. In the midst of the chaos, they found humor as Mitchell used the opportunity to teach his kids about public behavior and responsibility.  But life's not all fun and games, and sometimes, the unexpected happens.Imagine you go for a routine check-up, and you find out you might have kidney cancer. That's what happened to Mitchell. His initially scary journey of discovering a potential cancerous growth on his kidney became a testament to his faith. We discuss his diagnosis, the numerous appointments, and the upcoming surgery to remove his kidney. Despite the seriousness of the situation, Mitchell's optimism shines through, encouraging listeners to be proactive about their health and the power of positivity.In the final part of our podcast, Michele shares her deeply personal testimony, revealing how unexpected events like Mitchell's kidney cancer diagnosis showcase God's mysterious ways. We invite you to join our discussion and share our podcast, as we spread the good news of Jesus Christ. So, subscribe to our channel, and let's walk this journey of faith together.Support the showSupport our ministryCheck us out at purefaithliving.comContact us at purefaithliving.com/contactFollow us on twitter @purefaithlivingFollow us on Facebook at Pure Faith Podcast

Have you ever wondered how music can guide us through life's ups and downs? Meet our guest, David, whose story is a testament to the therapeutic power of music. Between battling kidney cancer, and spinal stenosis, and confronting his tumultuous past marked by wild adventures and a challenging relationship with psychedelic substances, David discovered solace and expression in music. His playlist mirrors his life's rollercoaster ride and reveals how he found a meditative escape in the hospital's confines during his health crisis.Get ready for an exhilarating ride as David peels back the layers of his popular show, Discograffiti Podcast Here, musicians, filmmakers, and authors share their creative journeys, offering listeners a condensed glimpse into their artistry. Listen as David passionately talks about his favorite tracks, films, and musicians, including the unexpected joy he finds in Phil Collins' music. David also shares his unique interpretation of the Rolling Stones' lead-off track, 'Rocks Off'. We'll also explore David's journey in filmmaking, the hardships he's faced in funding his projects, and how these experiences seep into the narratives of his films. David's story is a compelling tale of resilience and the transformative power of music. Don't miss out on this inspiring episode.Watch the full episode on YouTubeCheck out the Playlist on SpotifyFollow us EverywhereMake sure to HIT that LIKE BUTTON and SUBSCRIBE to our Channel to be notified of new episodes!Please share our page with your friends! A new episode is out every Monday at 12 pm Rock onSupport the show

This week on BackTable Urology, Dr. Aditya Bagrodia (UCSD), medical oncologist Dr. Rana McKay (UCSD) and radiation oncologist Dr. Shankar Siva (University of Melbourne) discuss the growing role of radiation therapy in kidney cancer treatment. --- SHOW NOTES Shankar first explains the original historical studies that provided evidence of the limited efficacy of low dose conventional radiation therapy (RT) in treating kidney cancer. However, he and Rana discuss how stereotactic body radiation therapy (SBRT), a newer technology which delivers a higher dose per fraction more accurately, has shown better outcomes in clinical trials than conventional RT. They also explain the associated risks with SBRT and how neoadjuvant therapies can be combined with radiation. They also consider the use of SBRT in bulky tumors and those with IVC thrombus. All three doctors agree that radiation therapy needs to be incorporated into a multimodal approach to kidney cancer. They also discuss the potential of radiation therapy in the cytoreductive setting and its role in delaying systemic therapy in patients with oligometastases. Finally, they explore the possibility of using PET imaging to detect oligometastatic disease. Although prostate-specific membrane antigen positron emission tomography (PSMA PET/CT) imaging is mostly used to stage prostate cancer, other solid tumors like renal cell carcinoma (RCC) may also express PSMA. For this reason, they agree that a next generation PSMA PET/CT equivalent for RCC could be revolutionary. Lastly, they predict what the future of RCC could hold by examining newer therapies, such as radioligand therapy and cyberknife. --- RESOURCES Kidney Cancer Association: 2023 International Kidney Cancer Symposium (Nov. 9-11) https://www.kidneycancer.org/ikcs/2023-ikcs-north-america/ Decipher by Veracyte https://decipherbio.com/ WellPrept https://wellprept.com/